The study could distinguish cancer and normal cells by scanning as few as 250 RNA molecules obtained from tissue samples. This is a fraction of what a typical nanopore sequencing device is capable of.
Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant or postpartum women who initially received unusual or nonreportable ...
Supported by the BBVA Foundation to C.M.C.; ISCIII (PI22_00720), Asociación Española Contra el Cáncer (AECC CLSEN20004SERR), and CRIS Cancer Foundation (excellence2023_44), all to C.S. The following ...
Virginia G. Kaklamani, MD, DSc, discusses datopotamab deruxtecan and other antibody-drug conjugates available for patients with unresectable or metastatic hormone receptor-positive, HER2-negative ...